BAALC and breast cancer: We next assessed whether BAALC expression was associated with breast cancer patient outcome by investigating BAALC mRNA expression in a publicly available 3,935-sample breast cancer data set, where high BAALC expression was not linked to OS (Figure 2A, p=0.14), but specifically associated with significantly worse DMFS (Figure 2B, p=0.014) (32).